. . . . . . . . . . . . . . . . "kin(p(SFAM:\"MAPK JNK Family\")) -> r(HGNC:HIPK3)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "Consequently, we have used the recently described specific JNK inhibitor SP600125 and RNA interference to inhibit endogenous JNK activity in the prostate carcinoma cell line DU 145. We demonstrated that endogenous JNK activity increased the expression of a kinase, HIPK3, that has previously been implicated in multidrug resistance in a number of tumors." . . "Selventa" . . . . "2014-07-03T14:32:16.192+02:00"^^ . . .